Cite
HARVARD Citation
Shi, G. et al. (2021). Graft Programmed Death Ligand 1 Expression as a Marker for Transplant Rejection Following Anti–Programmed Death 1 Immunotherapy for Recurrent Liver Tumors. Liver transplantation. 27 (3), pp. 444-449. [Online].